Literature DB >> 24680949

Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institution.

Alizée Caplain1, Youenn Drouet2, Mathilde Peyron3, Marie Peix4, Christelle Faure1, Catherine Chassagne-Clément3, Frédéric Beurrier1, Marie-Eve Fondrevelle3, Nicole Guérin4, Christine Lasset2, Isabelle Treilleux5.   

Abstract

BACKGROUND: Because of underestimation, surgical excision is recommended for atypical ductal hyperplasia diagnosed on directional vacuum-assisted biopsies. The following guidelines have been established according to our retrospective study published in 2008: excision for lesions ≥ 21 mm, follow-up for lesions <6 mm with complete removal of microcalcifications, and follow-up or excision for 6 to 21-mm lesions with respectively less or >2 atypical ductal hyperplasia foci. METHODS AND
RESULTS: These guidelines were assessed in a prospective series of 124 patients with a median follow-up of 30 months. Conformity rate was 92%. Upgrading was 28% (15 of 53 patients) for conformed surgery and absent for surgery performed beyond the scope of guidelines. For the patients with benign result at surgery (n = 38) or just followed (n = 61), 3 cancers occurred in either breast at 1 to 3 years.
CONCLUSIONS: These convenient guidelines can safely spare surgery for a subset of patients. However, annual mammographic follow-up is recommended since the risk of subsequent cancer remains high for both breasts.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical ductal hyperplasia; Directional vacuum-assisted biopsy; Mammographic follow-up; Prospective study; Surgical excision; Upstaging–underestimation

Mesh:

Year:  2014        PMID: 24680949     DOI: 10.1016/j.amjsurg.2013.10.029

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  2 in total

Review 1.  Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions.

Authors:  Thaer Khoury
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

2.  Clinical predictors of malignancy in patients diagnosed with atypical ductal hyperplasia on vacuum-assisted core needle biopsy.

Authors:  Diana Hodorowicz-Zaniewska; Karolina Brzuszkiewicz; Joanna Szpor; Wojciech Kibil; Andrzej Matyja; Katarzyna Dyląg-Trojanowska; Piotr Richter; Antoni M Szczepanik
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-02-15       Impact factor: 1.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.